Accent Capital Management’s AbbVie ABBV Stock Holding History

Accent Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$888K	Buy	+3,530	New	+$759K	0.38%	40
2024 Q4	–	Sell	-1,500	Closed	-$296K	–	190
2024 Q3	$296K	Hold	1,500	–	–	0.17%	52
2024 Q2	$257K	Hold	1,500	–	–	0.16%	49
2024 Q1	$273K	Sell	1,500 -2,000	-57%	-$345K	0.24%	39
2023 Q4	$542K	Buy	+3,500	New	+$510K	0.43%	38

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Accent Capital Management's ABBV Position: Q2 2026 in Review

Accent Capital Management opened a new position in AbbVie (ABBV) in Q2 2026: 3,530 shares worth $888K. The stake represents 0.38% of the portfolio and ranks #40 among its holdings. This is a return to the name: Accent Capital Management previously reported a position in ABBV as recently as Q3 2024.

Accent Capital Management first reported a position in ABBV in Q4 2023 and has held it in 5 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Accent Capital Management held 3,530 shares of AbbVie worth $888K as of Q2 2026.
AbbVie was a new Accent Capital Management position in Q2 2026.
AbbVie made up 0.38% of Accent Capital Management's portfolio in Q2 2026, its #40 holding.
Accent Capital Management first reported a position in AbbVie in Q4 2023 and has held it in 5 quarters since.
4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Accent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.